As a research center embedded within Kaiser Permanente’s large and dynamic health care system, our investigators have a unique opportunity to apply scientific expertise to real-world clinical problems, translate findings into practice, and share what we learn with the broader community.
Dr. Mukherjee is an epidemiologist and post-doctoral research fellow in the Department of Research & Evaluation. Her research interests include human papillomavirus-associated cancers, comorbidities in cancer patients and survivors, and development of risk prediction models using electronic health records and cancer registry data.
Before joining Kaiser Permanente, Dr. Mukherjee worked as an American Heart Association pre-doctoral fellow at the University of Alabama at Birmingham. Her ...
Over the years, clinical trials have led to amazing advances in treatment—even cures—for devastating illnesses. William Towner, MD, FACP, FIDSA, regional physician director for clinical trials, describes how trials at Kaiser Permanente contribute to the development of more effective and safer treatments for diseases such as HIV, hepatitis C, cancer, and more. (2:15)
It’s well established – but not widely known – that smoking cigarettes increases the risk of bladder cancer. Now, new research shows that current and former smokers are also at higher risk of having their bladder cancer recur after treatment. The study, published November 30 in JAMA Network Open, analyzed data from the Be-Well Study, ...
A study of nearly 2 million pediatric Kaiser Permanente members reinforces known links between children’s chances of experiencing a firearm injury and certain risk factors — especially being an adolescent male. The study, which appeared recently in Academic Pediatrics, addresses a number of additional risk factors, providing a broad view of the risk of firearm ...
COVID-19 is a respiratory illness, so it’s not surprising that exposure to poor air quality worsens patient outcomes. But how does air pollution affect people who are vaccinated? To answer that question, a team of researchers analyzed data from more than 50,000 Kaiser Permanente Southern California COVID-19 patients. By comparing publicly available air quality monitoring ...
Early detection and screening of breast cancer has allowed most women to thrive long after their diagnosis. However, women of color persistently experience disparities in outcomes. Researchers at the Kaiser Permanente Southern California Department of Research & Evaluation have been working to find ways to reduce these disparities and improve the survival rates for all ...
A maternal and child health epidemiologist, Nana Mensah, PhD, MPH, is in the first year of her post-doctoral program at the Kaiser Permanente Southern California Department of Research & Evaluation. Through her research working with the Kaiser Permanente Southern California Pregnancy Registry, she seeks to understand how clinical guidelines and practices shape birth outcomes in ...
In this issue of IMPACT, we share new research on firearm injuries among young people, breast cancer survival rates, and air pollution and COVID-19 outcomes. You also can see job openings, and help us make the newsletter better in the future.
Our behavioral scientists focus on research that has the potential to reduce disease risk by identifying modifiable risk factors and encouraging health-promoting behaviors. Faculty members have expertise in the following areas: adverse childhood experiences, cancer, chronic disease prevention and screening, diet and nutrition, mental health, obesity, physical activity, sedentary behavior, social determinants of health, and weight loss surgery and interventions.
The behavioral research portfolio includes intervention studies as well as qualitative and quantitative studies. The division also supports recruitment and other activities of the Kaiser Permanente Research Bank in Southern California.